GSK2656157 is a highly specific and ATP-competitive PERK inhibitor (IC50: 0.9 nM) in a cell-free assay. The selectivty is 500-fold higher against a panel of 300 kinases.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 90 | |
4 mg | In stock | $ 153 | |
8 mg | In stock | $ 214 | |
20 mg | In stock | $ 410 | |
40 mg | In stock | $ 631 |
Description | GSK2656157 is a highly specific and ATP-competitive PERK inhibitor (IC50: 0.9 nM) in a cell-free assay. The selectivty is 500-fold higher against a panel of 300 kinases. |
Targets&IC50 | PERK: 0.9 nM |
In vitro | Antiproliferative activity of GSK2656157 against multiple human tumor cell lines as well as primary human microvascular endothelial cells is evaluated in a 3-day proliferation assay using standard culture medium. In the absence of exogeneous UPR inducers, GSK2656157 has no significant effect on the growth of any of these cells with IC50 range of 6–25 mM. (Only for Reference) |
CAS No. | 1337532-29-2 |
Chemical Formula | C23H21FN6O |
Molecular Weight | 416.46 |
Solubility | H2O: <1 mg/mL Ethanol: <1 mg/mL; DMSO: 30 mg/mL (72 mM) |
Storage | Powder: -20°C for 2 years In solvent: -80°C for 1 year |
bottom